Palmer, Jerry P.

Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function

Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes

Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 1,405

Insulin antibodies in insulin-dependent diabetics before insulin treatment

Palmer, J. P., Asplin, C. M., Clemons, P., Lyen, K., Tatpati, O., Raghu, P. K., & Paquette, T. L. (1983) · Science

Diabetes and associated disordersDiabetes Management and Research

Cited by 1,078

Differentiation of diabetes by pathophysiology, natural history, and prognosis

Skyler, J. S., Bakris, G. L., Bonifacio, E., Darsow, T., Eckel, R. H., Groop, L., Groop, P.-H., Handelsman, Y., Insel, R. A., Mathieu, C., et al. (2017) · Diabetes

Diabetes and associated disordersDiabetes Management and Research

Cited by 823

C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve β-Cell Function

Palmer, J. P., Fleming, G. A., Greenbaum, C. J., Herold, K. C., Jansa, L. D., Kolb, H., Lachin, J. M., Polonsky, K. S., Pozzilli, P., Skyler, J. S., et al. (2004) · Diabetes

Diabetes and associated disordersDiabetes Management and Research

Cited by 491

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

Wherrett, D. K., Bundy, B., Becker, D. J., DiMeglio, L. A., Gitelman, S. E., Goland, R., Gottlieb, P. A., Greenbaum, C. J., Herold, K. C., Marks, J. B., et al. (2011) · The Lancet

Diabetes and associated disordersDiabetes Management and Research

Cited by 371

GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus

Ludvigsson, J., Krisky, D., Casas, R., Battelino, T., Castaño, L., Greening, J., Kordonouri, O., Otonkoski, T., Pozzilli, P., Robert, J.-J., et al. (2012) · New England Journal of Medicine

Diabetes and associated disordersDiabetes Management and Research

Cited by 340

Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function

Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., Palmer, J. P., et al. (1993) · Diabetes

Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 328

Fall in C-Peptide During First 2 Years From Diagnosis

Greenbaum, C. J., Beam, C. A., Boulware, D., Gitelman, S. E., Gottlieb, P. A., Herold, K. C., Lachin, J. M., McGee, P., Palmer, J. P., Pescovitz, M. D., et al. (2012) · Diabetes

Diabetes and associated disordersDiabetes Management and Research

Cited by 319

Impact of C-peptide preservation on metabolic and clinical outcomes in the Diabetes Control and Complications Trial

Lachin, J. M., McGee, P., Palmer, J. P., & for the DCCT/EDIC Research Group (2014) · Diabetes

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 283

Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1

Orban, T., Sosenko, J. M., Cuthbertson, D., Krischer, J. P., Skyler, J. S., Jackson, R., Yu, L., Palmer, J. P., Schatz, D., Eisenbarth, G., et al. (2009) · Diabetes Care

Diabetes and associated disordersDiabetes Management and Research

Cited by 260

Latent Autoimmune Diabetes in Adults

Naik, R. G., Brooks-Worrell, B. M., & Palmer, J. P. (2009) · The Journal of Clinical Endocrinology & Metabolism

Diabetes and associated disordersDiabetes Management and Research

Cited by 249

Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes

Graham, J., Hagopian, W. A., Kockum, I., Li, L. S., Sanjeevi, C. B., Lowe, R. M., Schaefer, J. B., Zarghami, M., Day, H. L., Landin-Olsson, M., et al. (2002) · Diabetes

Diabetes and associated disordersGenetic Associations and Epidemiology

Cited by 230

Impact of insulin and metformin versus metformin alone on β-cell function in youth with impaired glucose tolerance or recently diagnosed type 2 diabetes

The RISE Consortium, Nadeau, K. J., Hannon, T. S., Edelstein, S. L., Arslanian, S. A., Caprio, S., Leschek, E. W., Zeitler, P. S., Buchanan, T. A., Ehrmann, D. A., et al. (2018) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 176

Is latent autoimmune diabetes in adults distinct from type 1 diabetes or just type 1 diabetes at an older age?

Palmer, J. P., Hampe, C. S., Chiu, H., Goel, A., & Brooks-Worrell, B. M. (2005) · Diabetes

Diabetes and associated disordersDiabetes Management and Research

Cited by 136

Effects of exenatide alone and in combination with daclizumab on β-cell function in long-standing type 1 diabetes

Rother, K. I., Spain, L. M., Wesley, R. A., Digon, B. J., Baron, A., Chen, K., Nelson, P., Dosch, H.-M., Palmer, J. P., Brooks-Worrell, B., et al. (2009) · Diabetes Care

Diabetes Treatment and ManagementDiabetes and associated disorders

Cited by 133

The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients

Sosenko, J. M., Skyler, J. S., Palmer, J. P., Krischer, J. P., Yu, L., Mahon, J., Beam, C. A., Boulware, D. C., Rafkin, L., Schatz, D., et al. (2013) · Diabetes Care

Diabetes and associated disordersDiabetes Management and Research

Cited by 123

Β cell dysfunction exists more than 5 years before type 1 diabetes diagnosis

Evans-Molina, C., Sims, E. K., DiMeglio, L. A., Ismail, H. M., Steck, A. K., Palmer, J. P., Krischer, J. P., Geyer, S., Xu, P., Sosenko, J. M., et al. (2018) · JCI Insight

Diabetes and associated disordersDiabetes Management and Research

Cited by 116

Standardization of C-peptide measurements

Little, R. R., Rohlfing, C. L., Tennill, A. L., Madsen, R. W., Polonsky, K. S., Myers, G. L., Greenbaum, C. J., Palmer, J. P., Rogatsky, E., & Stein, D. T. (2008) · Clinical Chemistry

Clinical Laboratory Practices and Quality ControlScientific Measurement and Uncertainty Evaluation

Cited by 103

A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history

Sosenko, J. M., Skyler, J. S., DiMeglio, L. A., Beam, C. A., Krischer, J. P., Greenbaum, C. J., Boulware, D., Rafkin, L. E., Matheson, D., Herold, K. C., et al. (2015) · Diabetes Care

Diabetes and associated disordersDiabetes Management and Research

Cited by 86

Residual β cell function in long-term type 1 diabetes associates with reduced incidence of hypoglycemia

Gubitosi-Klug, R. A., Braffett, B. H., Hitt, S., Arends, V., Uschner, D., Jones, K., Diminick, L., Karger, A. B., Paterson, A. D., Roshandel, D., et al. (2021) · Journal of Clinical Investigation

Diabetes and associated disordersDiabetes Management and Research

Cited by 86

Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants

Sosenko, J. M., Skyler, J. S., Beam, C. A., Krischer, J. P., Greenbaum, C. J., Mahon, J., Rafkin, L. E., Matheson, D., Herold, K. C., Palmer, J. P., et al. (2013) · Diabetes

Diabetes and associated disordersDiabetes Management and Research

Cited by 85

Identification of Autoantibody-Negative Autoimmune Type 2 Diabetic Patients

Brooks-Worrell, B. M., Reichow, J. L., Goel, A., Ismail, H., & Palmer, J. P. (2011) · Diabetes Care

Diabetes and associated disordersPancreatic function and diabetes

Cited by 83

Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1

Sosenko, J. M., Palmer, J. P., Rafkin-Mervis, L., Krischer, J. P., Cuthbertson, D., Mahon, J., Greenbaum, C. J., Cowie, C. C., Skyler, J. S., & the Diabetes Prevention Trial–Type 1 Study Group (2009) · Diabetes Care

Diabetes and associated disordersDiabetes Management and Research

Cited by 76

Lack of durable improvements in β-cell function following withdrawal of pharmacological interventions in adults with impaired glucose tolerance or recently diagnosed type 2 diabetes

The RISE Consortium, Ehrmann, D. A., Temple, K. A., Rue, A., Barengolts, E., Mokhlesi, B., Van Cauter, E., Sam, S., Miller, M. A., Kahn, S. E., et al. (2019) · Diabetes Care

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 73